Sideman S, Lotan N, Tabak A, Manor D, Mor L, Taitelman U, Brook J, Tzipiniuk A
Appl Biochem Biotechnol. 1984;10:167-82. doi: 10.1007/BF02783749.
Composite beads of approximately 1 mm diameter, made of crosslinked agarose and containing Fuller's Earth or zirconium oxide powders, were prepared and used in extracorporeal systems for blood detoxification. The former was used for the removal of Paraquat, while the latter was used to remove inorganic phosphate from hyperphosphatemic animals with or without acute renal failure. The high surface area of the powder, combined with the low resistance to diffusion in the crosslinked agarose matrix, are highly advantageous. The crosslinking provides high mechanical strength, heat stability, prolonged shelf life, good blood flow characteristics, and prevents the release of fine particles into the blood. Crosslinked agarose beads of 1 mm diameter, containing chemically-bound heparin were also prepared, and used as a model for direct contact removal of LDL-cholesterol from the blood of familial hypercholesterolemic patients by hemoperfusion. The high capacity of these beads (over 5 mg LDL/mL beads) indicates that this clinical modality can replace the highly expensive plasmapheresis procedure presently used.
制备了直径约1毫米的复合珠,由交联琼脂糖制成,含有富勒土或氧化锆粉末,并用于体外血液解毒系统。前者用于去除百草枯,而后者用于从患有或未患有急性肾衰竭的高磷血症动物体内去除无机磷酸盐。粉末的高表面积,加上在交联琼脂糖基质中低扩散阻力,具有很大优势。交联提供了高机械强度、热稳定性、延长的保质期、良好的血流特性,并防止细颗粒释放到血液中。还制备了直径1毫米、含有化学结合肝素的交联琼脂糖珠,并用作通过血液灌流从家族性高胆固醇血症患者血液中直接接触去除低密度脂蛋白胆固醇的模型。这些珠子的高容量(超过5毫克低密度脂蛋白/毫升珠子)表明这种临床方式可以取代目前使用的极其昂贵的血浆置换程序。